We are live on ! Find out more
CRVS icon

Corvus Pharmaceuticals

48 hedge funds and large institutions have $34.2M invested in Corvus Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $28M → $34.2M (+$6.21M)

18% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 11

0.47% more ownership

Funds ownership: 39.18%39.65% (+0.47%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less funds holding

Funds holding: 5248 (-4)

45% less call options, than puts

Call options by funds: $86K | Put options by funds: $157K

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
48
Holders Change
-4
Holders Change %
-7.69%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
3
Increased
13
Reduced
11
Closed
7
Calls
$86K
Puts
$157K
Net Calls
-$71K
Net Calls Change
-$72K
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
51
Invesco
Georgia
-$22.8K -15,617 Closed
HF
52
HRT Financial
New York
-$19K -13,050 Closed
TSS
53
Two Sigma Securities
New York
-$16.4K -11,232 Closed
Fidelity Investments
54
Fidelity Investments
Massachusetts
-$1.61K -1,101 Closed
Royal Bank of Canada
55
Royal Bank of Canada
Ontario, Canada
+$178 +122 New